Search

Home > GRACEcast Lung Cancer Video > How do we approach acquired resistance to targeted therapies in lung cancer?
Podcast: GRACEcast Lung Cancer Video
Episode:

How do we approach acquired resistance to targeted therapies in lung cancer?
Category: Science & Medicine
Duration: 00:05:51
Publish Date: 2013-07-04 18:36:29
Description:

Drs. Jack West, Mary Pinder, and Nate Pennell discuss options for managing acquired resistance to EGFR TKIs and ALK inhibitors in patients with advanced NSCLC and a driver mutation.
Total Play: 0